Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
26 April 2021 | Story Dr Emmanuel Mayeza
Dr Emmanuel Mayeza
Dr Emmanuel Mayeza is a Senior Lecturer in the Department of Sociology at the University of the Free State.

Opinion article by Dr Emmanuel Mayeza, a Senior Lecturer in the Department of Sociology, University of the Free State

On Monday 12 April 2021, Lufuno Mavhunga, a 15-year-old female learner at Mbilwi Secondary School in Limpopo, South Africa, was aggressively assaulted by another learner at school. The video showing the humiliating violent attack was circulated on various social media platforms. Sadly, Lufuno subsequently died as a result of suicide. During the bullying incident, bystanders (her school mates) watched, cheered, laughed, and recorded videos of the incident. The alleged perpetrator (another 14-year-old female learner at the same school) has since been arrested by the police and charged with assault. The school will institute disciplinary action against the bystanders who failed to assist and protect Lufuno. Lufuno’s family, however, believes that the school did not do enough to support Lufuno after the incident was reported to the school principal.

The victimisation of Lufuno could have been prevented, and I will show in this article what can be done to stop and prevent bullying in South African schools.

Suicide: the ultimate consequence of being bullied at school

Lufuno’s victimisation and her tragic death highlight the scourge, as well as the seriousness, of the problem of bullying in South African schools. School-based bullying has various consequences for everyone at school, but victims often incur the most devastation from bullying. The consequences of being bullied at school include the development of psychological and emotional problems such as distress, damaged self-esteem, anxiety, depression, and suicidal thoughts. If these problems are not addressed timeously or appropriately, it could ultimately result in suicide. Although Lufuno’s victimisation was reported to the school authorities, the deceased young victim did not receive any professional psychological counselling following the traumatic experiences of being bullied and the video of this incident being shared on social media. It seems that the victim dealt with the bullying mostly by herself and that the people who knew about the bullying did not take her ordeal and anxieties seriously enough.

Bullying is gendered and complex: Girls as victims and as bullies

Bullying is a form of gender violence. It is based on the asymmetrical relations of power that are prevalent in our patriarchal society. The key feature of such relations is men and boys assuming authority, domination, and control through violence against girls, women, and femininities. However, Lufuno’s victimisation draws our attention to the complexities of bullying and gender power relations among learners at school. Although boys and men often emerge as perpetrators of violence against girls and women, bullying in schools is a complex issue and girls are not always the passive victims of male violence.  Both girls and boys can become victims and bullies. Bullying is an expression of power, and girls too are capable of expressing power through forms of violence against other girls and against some boys. Indeed, a recent study on bullying among learners in a South African primary school highlights the vulnerability of younger boys to violence perpetrated by older girls at school ( https://doi.org/10.15700/saje.v41n1a1858 ). Therefore, we must acknowledge that the victimisation of Lufuno by another girl is not something unique. Gender relations are dynamic, and we can see that girls too have learnt how to use violence to express power and to claim dominance over other learners in schools.

What needs to be done to stop and prevent school-based bullying? 

While the processes of the criminal justice system regarding Lufuno’s victimisation are underway, effective prevention programmes are also required in order to stop bullying at school. Such programmes must be designed with the view to empower everyone at school with skills and knowledge on how to prevent bullying from happening, and how to react appropriately when bullying is witnessed or reported. To end bullying, the school should consider addressing bystanders, improving the availability of professional support services to victims of bullying, re-thinking the curriculum, and establishing stronger partnerships with other stakeholders.

All learners at the school must be addressed in terms of the roles that they can play as active bystanders who are committed to ending bullying. Bystanders must be empowered so that they know what bullying constitutes and are able to see when bullying happens and know how to intervene appropriately to stop it and protect the victim. They must know the seriousness of bullying and its consequences, and that this includes suicide. Bystanders must understand that posting a video or a photo on social media showing someone being abused is in itself also a form of bullying. Bystanders must be informed that they have a responsibility to report any form of bullying they witness at school to the school authorities or to their parents or guardians.

When learners have reported bullying, school authorities need to take the reported incident seriously and act appropriately, especially in terms of supporting the victim. To reduce the risk of victims committing suicide, professional psychological counselling support must be offered to the victims without delay. However, the risk of committing suicide among victims of bullying can only be significantly reduced if proper resources and victim support services are available at the school. The lack of such resources and services at Mbilwi Secondary School presents a major risk for victims to resort to suicide.  

The school should also explore possibilities of developing learning programmes that will foreground bullying and raise awareness about this serious issue. Such programmes should be compulsory for all learners and must be designed to encourage learners to speak out about their experiences, perceptions, and anxieties around bullying. Consequences of bullying and what needs to be done to stop and prevent school-based bullying should also form part of the topics for discussion within such learning programmes.

However, the school cannot be successful in its efforts towards ending bullying if it acts alone. The violent behaviour that learners demonstrate at school reflects, to a large extent, the normalised violence within households and communities. The school, therefore, must form strong partnerships with parents, communities, government, religious institutions, and other relevant stakeholders to explore effective ways of addressing bullying at school. The school must engage productively with these different stakeholders, and such engagements should also include learners’ voices and perspectives on the issue of bullying and how to end it.

News Archive

Cardiology Unit involved in evaluation of drug for rare genetic disease
2013-01-04

Front from the left, are: Marinda Karsten (study coordinator and registered nurse),
Laumarie de Wet (clinical technologist), Charmaine Krahenbuhl (study coordinator and radiographer),
Lorinda de Meyer (administrator), Andonia Page (study coordinator and enrolled nurse);
back Dr Gideon Visagie (sub investigator), Dr Derick Aucamp (sub investigagtor),
Prof. Hennie Theron, (principal investigator) and Dr Wilhelm Herbst (sub investigator).
Photo: Supplied
09 January 2013


The Cardiology Research Unit at the University of the Free State (UFS) contributed largely to the evaluation of the drug Juxtapid (lomitapide), which was developed by the Aegerion pharmaceutical company and approved by the FDA (Federal Drug Administration). Together with countries such as die USA, Canada and Italy, the UFS’ Unit recruited and evaluated the most patients (5 of 29) for the study since 2008.  

The drug was evaluated in persons with so-called familial homozygous hypercholesterolemia (HoFH).  

Following its approval by the FDA, Juxtapid is now a new treatment option for patients suffering from HoFH. The drug operates in a unique way which brings about dramatic improvements in cholesterol counts.  

According to Prof. Hennie Theron, Associate Professor in the Department of Cardiology at the UFS and Head of the Cardiology Contract Research Unit, HoFH is a serious, rare genetic disease which affects the function of the receptor responsible for the removal of low-density lipoprotein cholesterol (LDL-C) (“bad” cholesterol) from the body. Damage to the LDL receptor function leads to extremely high levels of blood cholesterol. HoFH patients often develop premature and progressive atherosclerosis, which is a narrowing or blockage of the arteries.  

“HoFH is a genetically transmitted disease and the most severe form of hypercholesterolemia. Patients often need a coronary artery bypass or/and aortic valve replacement before the age of 20. Mortality is extremely high and death often occurs before the third decade of life. Existing conventional cholesterol-lowering medication is unsuccessful in achieving normal target cholesterol values in this group of patients.  

“The only modality for treatment is plasmapheresis (similar to dialysis in patients with renal failure). Even with this type of therapy the results are relatively unsatisfactory because it is very expensive and the plasmapheresis has to be performed on a regular basis.  

“The drug Juxtapid, as currently evaluated, has led to a dramatic reduction in cholesterol values and normal values were achieved in several people. No existing drug is nearly as effective.  

“The drug represents a breakthrough in the treatment of familial homozygous hypercholesterolemia. The fact that it has been approved by the FDA, gives further impetus to the findings,” says Prof. Theron.  

In future further evaluation will be performed in other forms of hypocholesterolemia.  

According to Prof. Theron, the findings of the study, as well as the recent successful FDA evaluation, once again confirms the fact that the UFS’ Cardiology Contract Research Unit is doing outstanding work.  

Since its inception in 1992, the Unit has already been involved in more than 60 multi-centre, international phase 2 and 3 drug studies. Several of these studies, including the abovementioned study, really affected the way in which cardiology functions.  

The UFS’ Cardiology Contract Research Unit is being recognised nationally and internationally for its high quality of work and is constantly approached for their involvement in new studies.  

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept